ArticleCancer research and treatment2017

Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity.

Jörg U Schmohl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.